American Journal of Gastroenterology Publishes Key Study Further Validating Esopredict® as a Prognostic Test for Barrett's Esophagus

BALTIMORE, Feb. 12, 2025 /PRNewswire/ -- Today, Previse, a gastrointestinal health company, announced a newly published study in the American Journal of Gastroenterology, which provides additional clinical validation of Esopredict®, the only commercially available test that uses DNA...